INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.810
-0.010 (-0.55%)
Dec 19, 2025, 3:06 PM EST - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $48.12 million as of December 19, 2025. Its market cap has decreased by -58.02% in one year.
Market Cap
48.12M
Enterprise Value
21.47M
1-Year Change
-58.02%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $48.12M, a decrease of -38.17%. That is a compound annual growth rate of -6.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 48.39M | -53.27% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | 231.57M | 270.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 949.85B |
| Johnson & Johnson | 503.52B |
| AbbVie | 397.82B |
| UnitedHealth Group | 297.58B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 247.95B |
| Abbott Laboratories | 219.09B |